The consequences of insulin-like growth factors/receptors dysfunction in lung cancer

Jasminka Pavelic1, Simun Krizanac, Sanja Kapitanovic

  • 1Division of Molecular Medicine, Rudjer Boskovic Institute, Bijenicka 54, P. Box 180, HR-10002 Zagreb, Croatia. jpavelic@irb.hr

Insights

Disruption of insulin-like growth factor (IGF) signaling pathways is linked to lung cancer development. Targeting IGF receptors with alphaIR3 may inhibit tumor growth and increase apoptosis in lung carcinomas.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Insulin-like growth factors (IGFs) and their receptors play crucial roles in cell growth and survival.
  • Dysregulation of the IGF signaling pathway is implicated in various cancers, including lung carcinoma.
  • Understanding the specific roles of IGFs and their receptors in different lung cancer subtypes is essential.

Purpose of the Study:

  • To investigate the role of insulin-like growth factors (IGF) and IGF receptor dysfunction in lung carcinomas.
  • To explore the correlation between IGF expression and apoptosis in lung cancer.
  • To examine the impact of targeting IGF receptors on lung cancer cell proliferation and apoptosis.

Main Methods:

  • Analysis of IGF-1 and IGF-1R mRNA and protein expression in lung carcinoma tissues.
  • Detection of loss of heterozygosity (LOH) and mutations in the M6P/IGF-2R gene.
  • In vitro studies using alphaIR3 antibody to assess its effects on lung cancer cell proliferation and apoptosis.
  • Measurement of telomerase activity in response to IGF-1 and alphaIR3 treatment.

Main Results:

  • Increased expression of IGF-1 and IGF-1R correlated with decreased apoptosis in large-cell carcinomas and adenocarcinomas.
  • Loss of heterozygosity (LOH) and mutations in the M6P/IGF-2R gene were observed in adenocarcinomas and squamous cell carcinomas.
  • The alphaIR3 antibody significantly reduced proliferation and increased apoptosis in squamous cell carcinoma cell cultures.
  • IGF-1 treatment enhanced telomerase activity, while alphaIR3 inhibited it in squamous cell carcinomas.

Conclusions:

  • Disruption of the IGF/IGF receptors axis is involved in lung cancer formation.
  • IGF signaling pathways represent potential therapeutic targets for lung cancer treatment.
  • Specific IGFs and their receptors may have distinct roles in different lung carcinoma subtypes.

Related Concept Videos

Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...